Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
Ozga M, Blachly J, Eisfeld AK, Grieselhuber N, Larkin K, Walker A, Bhatnagar B, Behbehani G, Long M, Haque T, Vasu S, Zhao W, Jones D, Byrd JC, Mims AS, Saygin C.
Ozga M, et al. Among authors: bhatnagar b.
Am J Hematol. 2021 Jul 1;96(7):E223-E225. doi: 10.1002/ajh.26170. Epub 2021 Apr 8.
Am J Hematol. 2021.
PMID: 33761147
Free article.
No abstract available.